NVS - Novartis AG's (NVS) CEO Vas Narasimhan on Q1 2021 Results - Earnings Call Transcript

Novartis AG (NVS) Q1 2021 Earnings Conference Call April 27, 2021 8:00 AM ET Company Participants Samir Shah – Global Head-Investor Relations Vas Narasimhan – Chief Executive Officer Marie-France Tschudin – President-Novartis Pharmaceuticals Richard Saynor – Chief Executive Officer-Sandoz Harry Kirsch – Chief Financial Officer John Tsai – Head-Global Drug Development and Chief Medical Officer for Novartis Susanne Schaffert – President-Novartis Oncology Conference Call Participants Mark Purcell – Morgan Stanley Graham Parry – Bank of America Andrew Baum – Citi Keyur Parekh – Goldman Sachs Emmanuel Papadakis – Deutsche Bank Matthew Weston – Credit Suisse Richard Parkes – Exane BNP Laura Sutcliffe – UBS Simon Baker – Redburn Wimal Kapadia – Bernstein Florent Cespedes – Societe Generale Richard Vosser – JPMorgan Mike Nedelcovych – Cowen Peter Welford – Jefferies Presentation Samir Shah Thank you very much. And good morning and good afternoon everybody. Thank you for taking the time to

For further details see:

Novartis AG's (NVS) CEO Vas Narasimhan on Q1 2021 Results - Earnings Call Transcript